Mice deficient in growth differentiation factor 11 (GDF11) signaling display anterior transformation of axial vertebrae and truncation of caudal vertebrae. However, the in vivo molecular mechanisms by which GDF11 signaling regulates the development of the vertebral column have yet to be determined. We found that Gdf11 and Acvr2b mutants are sensitive to exogenous RA treatment on vertebral specification and caudal vertebral development. We show that diminished expression of Cyp26a1, a retinoic acid inactivating enzyme, and concomitant elevation of retinoic acid activity in the caudal region of Gdf11 −/− embryos may account for this phenomenon. Reduced expression or function of Cyp26a1 enhanced anterior transformation of axial vertebrae in wild-type and Acvr2b mutants. Furthermore, a pan retinoic acid receptor antagonist (AGN193109) could lessen the anterior transformation phenotype and rescue the tail truncation phenotype of Gdf11 −/− mice. Taken together, these results suggest that GDF11 signaling regulates development of caudal vertebrae and is involved in specification of axial vertebrae in part by maintaining Cyp26a1 expression, which represses retinoic acid activity in the caudal region of embryos during the somitogenesis stage.
INTRODUCTION
The vertebral column consists of vertebrae, which protect the spinal cord and provide articulation for movement. Depending on the position and morphological characteristics along the anteroposterior (AP) axis, vertebrae are grouped into cervical, thoracic, lumbar, sacral and caudal vertebrae. The thoracic vertebrae are characterized by the attachment of ribs, and the sacral vertebrae are characterized by the formation of the sacrum. In mammals, from whales to giraffes, the number of cervical vertebrae is invariably seven except for a few species. The number of vertebrae in thoracic, lumbar and sacral regions in mammals is almost invariable within a species but considerably varies between species. For instance, mice have seven cervical (C), thirteen thoracic (T), six lumbar (L), four sacral (S), and over 20 caudal vertebrae, as represented by the C7T13L6S4 vertebral pattern, whereas the human, chimp and horse vertebrae display C7T12L5S5, C7T14L3S5 and C7T18L6S5 patterns, respectively. The vertebral pattern represents the hallmark of the metameric body plan along the AP axis that provides spatial cues for the development of the diaphragm and segmental structures such as the axial muscles, intercostal blood vessels, and projections of spinal nerve systems.
Each vertebra is formed from two adjacent pairs of somites, which also form occipital bones and ribs (Saga and Takeda, 2001) . Nascent somites are added to the last segmented somite at a relatively constant rate (about 2 hours in mice) from the presomitic mesoderm (PSM) region, while new mesoderm is concomitantly added at the posterior end of PSM from the tail bud. The manner in which somites acquire their positional information along the AP axis to exhibit their distinctive morphological characteristics has been studied extensively (Baker et al., 2006; Gregg, 2007; Saga and Takeda, 2001) . Transplantation experiments in chickens have shown that vertebral specification is established in the PSM region before the segmental plates bud off the PSM and develop into structurally identifiable nascent somites (Nowicki and Burke, 2000) . Ample comparative and genetic studies have shown that a specific array of Hox genes (a Hox code) is crucial for the specification of a vertebra (Wellik, 2007) . Among Hox genes, Hox10 and Hox11 paralogous genes have been shown to play a role in suppressing rib attachments to lumbar and sacral vertebrae and in the formation of the sacrum, respectively (Carapuco et al., 2005; Wellik and Capecchi, 2003) . Activities of these Hox genes in the PSM, but not in somites, are sufficient for global vertebral patterning (Carapuco et al., 2005) . However, the molecular mechanism by which a segmental plate acquires a specific Hox code is poorly understood.
Studies with gain-or loss-of-function mutations in mice have shown that a number of genes are involved in the regulation of multiple Hox genes and thereby affect vertebral patterning. These genes include the CDX family transcription factors (van den Akker et al., 2002) , Polycomb group global gene regulators (Akasaka et al., 2001; Core et al., 1997) , proteins involved in retinoic acid (RA) synthesis, metabolism, and signaling (Abu-Abed et al., 2001; Abu-Abed et al., 2003; Allan et al., 2001; Kessel, 1992; Kessel and Gruss, 1991; Sakai et al., 2001) , and proteins involved in GDF11 signaling (Andersson et al., 2006; McPherron et al., 1999; Oh and Li, 1997; Szumska et al., 2008) . In this paper we focus on the interactions between RA metabolism and GDF11, two signaling systems involved in vertebral patterning.
Exogenous administration of RA to pregnant females at 8.5 days post coitum (dpc) induces the posterior shift of the Hox code and anterior transformation of vertebrae, resulting in C7/ T14/L6 or C7/T15/L5 patterns (Kessel and Gruss, 1991) . Homeostasis of RA activity in the caudal region of embryo is essential for the vertebral patterning and the development of caudal vertebrae. In normal mice, RA is inactivated in the caudal region by a cytochrome P450 enzyme, CYP26A1, which catabolizes RA to 4-hydroxy RA (White et al., 1996; Pearlman, 2002) . Repression of RA is essential for the expression of a number of genes, such as Wnt3a, Fgf8 and bracyury, in the tail bud region (Abu-Abed et al., 2001; Abu-Abed et al., 2003; Sakai et al., 2001) . Mice deficient in Cyp26a1 exhibit markedly elevated RA activity in the tail bud, homeotic transformation of vertebrae, and caudal agenesis (Abu-Abed et al., 2001; Abu-Abed et al., 2003; Sakai et al., 2001) . Moreover, RA receptor deficiency can rescue the axial vertebral defects of Cyp26a1-null mice, demonstrating that elevated RA in the caudal region is the cause of the vertebral defects in Cyp26a1 −/− mice (Abu-Abed et al., 2003) .
GDF11 is a member of the transforming growth factor-β (TGF-β) superfamily and is involved in axial vertebral patterning and development of the palate, kidney, and pancreas (Dichmann et al., 2006; Esquela and Lee, 2003; McPherron et al., 1999) . The active form of TGF-β superfamily proteins is generated by proteolytic cleavage of the precursor protein. Recent studies have shown that proprotein convertase PCSK5 (PC5/6) is necessary for the activation of Gdf11 Seidah et al., 2008; Szumska et al., 2008) . The TGF-β family signal is transduced through interactions with heteromeric complexes of type II and type I receptors (Massague, 1998) . Activin type II receptors (ACVR2A and ACVR2B) and the TGF-β type I receptor (ALK5; TGFBR1) have been shown to mediate the GDF11 signal for vertebral specification (Andersson et al., 2006; Oh and Li, 1997; Oh et al., 2002) . SMAD2 and SMAD3 are known cytoplasmic targets of ACVR2/2B and ALK5 (Massague, 1998; Oh et al., 2002) .
Gdf11 −/− mice exhibit anterior transformations of the axial skeleton, resulting in an increased number of thoracic and lumbar vertebrae (C7/T18/L8) and truncation of caudal vertebrae (McPherron et al., 1999) . GDF11 has functional redundancy with GDF8 (myostation; Mstn) in patterning and development of the axial skeleton (McPherron et al.,, 2009 ): most Gdf11 −/− ;Mstn −/− mice have an increase in severity of anterior transformation (mostly 20 thoracic vertebrae) and tail truncation (up to sacral vertebrae), as compared to Gdf11 −/− mice. The vertebral transformation defects of Gdf11 −/− ;Mstn −/− mice represent the most remarkable phenotype among all known vertebral patterning defects of multiple mutant mice in terms of the extent of the transformation. The closest phenotypic resemblance is found in mice with triple Hox gene deletion (Wellik and Capecchi, 2003; McIntyre, 2007) , suggesting that expressions of multiple Hox genes are affected in Gdf11 −/− mice. Consistent with this, it has been demonstrated that the expression boundaries of multiple Hox genes are shifted posteriorly in Acvr2b −/− , Gdf11 −/− , and Pcsk5 −/− mice McPherron et al., 1999; Oh and Li, 1997; Szumska et al., 2008) . However, the mechanism by which Gdf11 signaling controls multiple Hox genes for axial vertebral patterning remains unknown.
In this paper, we present data suggesting that GDF11 signaling is an important determinant for the RA gradient along the AP axis by regulating CYP26A1 expression in the tail bud region for proper vertebral specification and tail development.
MATERIALS AND METHODS

Mouse strains
All mouse strains used in this study are listed as follows: Gdf11-, Acvr2a-, Acvr2b-, Cyp26a1-knockout mice, and RARE-LacZ transgenic mice (McPherron et al., 1999; Oh and Li, 1997; Rossant et al., 1991; Sakai et al., 2001; Song et al., 1999; Yang et al., 1999) . Mice were maintained under standard specific-pathogen-free conditions and all animal procedures performed were reviewed and approved by the University of Florida and Johns Hopkins University School of Medicine Institutional Animal Care and Use Committee.
Mouse mating schemes
For monitoring the in vivo RA activity, Gdf11 +/− ;RARE-lacZ(+) and Acvr2b +/− ;RARE-lacZ(+) males were intercrossed with Gdf11 +/− and Acvr2b +/− females, respectively. Embryos were collected at E8.5 and E10.5 for X-gal staining. For genetic interaction between Acvr2b and Cyp26a1, Acvr2b −/− males were intercrossed with Acvr2b +/− ;Cyp26a1 +/− females, and the vertebral patterns of Acvr2b −/− ;Cyp26a1 +/− newborn pups were compared with those of Acvr2b −/− and Acvr2b +/− ;Cyp26a1 +/− pups. For the RA sensitivity study, Acvr2b −/− males were intercrossed with Acvr2b +/− ;Acvr2a +/− females. RA was administered to dams at 8.5 dpc as described below.
Administration of R115866, retinoic acid, and AGN193109
10 mM R115866 (Johnson & Johnson Co.) stock was made in DMSO and the aliquots were stored in −20°C freezer. The stock solution was diluted in PEG200 just prior to use and administered to pregnant dams at 8.5 dpc via oral gavage needles. All-trans RA (SigmaAldrich, St. Louis, MO) was dissolved in DMSO at 25 mg/ml and stored at −20°C in the dark. The RA stock solution was subjected to a 10-fold dilution in sesame oil and orally administrated to the pregnant mice at 8.5 dpc at a final concentration of 10 mg/kg of body weight. AGN193109 (Allergan Inc., Irvine, CA) was dissolved in DMSO at 1 mg/ml and stored at −20°C
freezer. The stock solution was diluted in corn oil just before use and administrated to pregnant dams at 8.5 and/or 9.5 dpc through oral gavage needles at a final concentration of 2 mg/kg of body weight.
Skeleton preparation
E17.5, E18.5, or newborn pups were subjected to skeleton preparations as previously described (Lee et al., 2006) . Mice were eviscerated and left in water overnight with gentle shaking. After further removal of skin, fat, muscle, and glands, the sample was fixed in 95% ethanol for 2 to 5 days. The sample was then stained overnight in alcian blue 8GX staining solution (0.15 mg/ ml in 80% ethanol and 20% glacial acetic acid), and rinsed with 95% ethanol. After the tissue debris was cleared in 2% KOH solution for 3 hr, the skeleton was stained with 0.005% alizarin red S in 2% KOH for 3 h. The stained skeleton was rinsed with 2% KOH and kept in 50% glycerol/PBS.
Whole-mount X-gal staining
To detect RA activities in E9.5 or E10.5 embryos, whole-mount X-gal staining was carried out as described previously (Joo et al., 2007) . Briefly, collected embryos were fixed in fixing solution (1% formaldehyde, 0.2% glutaraldehyde, 2 mM MgCl 2 , 5 mM EGTA, 0.02% NP-40 in PBS), rinsed three times with PBS, and stained in X-gal staining solution [5 mM K 3 Fe (CN) 6 , 5 mM K 4 Fe(CN) 6 , 2 mM MgCl 2 , 0.01% Deoxycholate sodium salt, 0.02% NP-40, 0.75 mg/ml X-gal in 100 mM phosphate buffer (pH7.3)] at 37°C overnight. Stained embryos were post-fixed in post-fixing solution (4% paraformaldehyde, 0.1% Tween 20 in PBS) at 4°C overnight.
Whole-mount in situ hybridization
For studying the expression patterns of MesP2, Aldh1a2, Gdf11, Cyp26a1, Fgf8, and Wnt3a in E9.0, E9.5 or E10.5 embryos, antisense RNA probes were produced by using a digoxigenin-UTP labeling kit (Roche Diagnostics Corporation, Indianapolis, IN). The MesP2 (Saga et al., 1997) , Aldh1a2 (Niederreither et al., 1997) , Gdf11 (McPherron et al., 1999) , and Fgf8 (Mahmood et al., 1995) probes were generated from the template DNAs as described previously. The Cyp26a1 and Wnt3a probes were obtained from Cyp26a1 EST clone (IMAGE clone No.:6334777) and Wnt3a cDNA (NM_009522, nt1180-2266), respectively. Wholemount in situ hybridization was performed as previously described (Wilkinson, 1992) . Genomic DNA isolated from yolk sac was used for genotyping embryos.
RESULTS AND DISCUSSION
Acvr2b and Gdf11 mutants are sensitive to exogenous RA treatment
Exposure of embryos to all-trans RA at a high dose (100 mg/kg bw) at 8.5 dpc has been shown to induce anterior transformations of vertebrae, resulting in C7/T14/L6 or C7/T15/L5 patterns with varied degrees of tail truncation (Kessel and Gruss, 1991; Kessel, 1992) . We showed previously that RA treatment of Acvr2b −/− embryos at 8.5 dpc with a low dose (10 mg/kg bw), which only moderately induces vertebral patterning defects in WT mice, intensified vertebral defects, resulting in a C7/T18/L6 pattern with truncation of tail (Oh and Li, 1997) , indicating that mice deficient in ACVR2B signaling are sensitive to exogenous RA exposure. Because the vertebral patterning defect in Acvr2b −/− mice (C7T16L6) is milder than that seen in Acvr2a +/− ;Acvr2b −/− mice (C7T17L7; Oh et al., 2002) , Gdf11 −/− mice (C7T18L8; McPherron et al., 1999) or Gdf11 −/− ;Mstn −/− mice (C7T20L8; McPherron et al., 2009), we sought to determine whether RA could have a similar exacerbating effect in embryos with a more severe patterning phenotype.
As shown in Figure 1 , RA increased the extent of transformations in both activin type II receptor compound mutant and Gdf11 −/− mice. RA-treated Acvr2a +/− ;Acvr2b −/− mice had further increases in the number of thoracic vertebrae (up to 20) with severe truncation of lumbar, sacral and caudal vertebrae (Fig. 1A,B) . RA treatment of Gdf11 −/− mice also resulted in increased thoracic vertebral number to T20 with reduced numbers of lumbar vertebrae and no sacral/ caudal vertebrae (Fig. 1C, D) . The vertebral patterns of the RA-treated Gdf11 −/− and Acvr2a +/− ;Acvr2b −/− mice are remarkably similar to each other and also very similar to those of Gdf11 −/− ;Mstn −/− mice (McPherron et al., 2009 ). Interestingly, Gdf11 +/− mice also showed a higher sensitivity to the RA treatment compared to their WT littermates. RA treatment (10 mg/kg bw) caused typical thoracolumbar transformations in both Gdf11 +/+ and Gdf11 +/− mice, but at a higher frequency in Gdf11 +/− mice (19/20) compared to Gdf11 +/+ mice (6/17). Moreover, RA reduced the number of caudal vertebrae by about 3 in Gdf11 +/+ mice (untreated vs. treated: 28 ± 2 vs. 25 ± 7) compared to about 13 in Gdf11 +/− mice (30± 2 vs. 17 ± 8).
These results clearly demonstrate that mice deficient in GDF11-ACVR2 signaling are sensitive to exogenous RA exposure. Phenotypic overlap (i.e. severe caudal truncation and anterior transformation) among Gdf11 −/− ;Mstn −/− mice (McPherron, 2009), high dose RA-treated WT embryos (Kessel, 1992) , and low dose RA treated Acvr2a/b and Gdf11 mutants (Fig. 1) suggested a mechanistic link between RA and GDF/ACVR2 signaling for vertebral patterning and tail development.
Cyp26a1 expression is diminished in the PSM region of Gdf11-null embryos RA levels along the AP axis are tightly regulated by specific distribution of both RAsynthesizing and RA-inactivating enzymes. During critical stages of somitogenesis for thoracic and lumbar vertebral development (E8.5-E10.5), the RA-synthesizing enzyme, ALDH1A2 (aldehyde dehydrogenase family 1 subfamily A2), is predominantly expressed in somites and lateral plate mesoderm but not in the presomitic and tailbud region ( Fig. 2A) (Niederreither et al., 1997) . Conversely, the RA-inactivating enzyme, CYP26A1, is expressed predominantly in the presomitic and tail bud region (Fig. 2B) (Sakai et al., 2001 ). This reciprocal expression pattern of RA-synthesizing and -inactivating enzymes may generate a gradient of RA activity along the AP axis, with diminishing RA levels toward the caudal end. The expression domain of Cyp26a1 overlaps with that of Gdf11, which is expressed in the tail bud and the PSM but not in mature somites (Fig. 2C) (Andersson et al., 2006; Nakashima et al., 1999) . We investigated whether the Cyp26a1 expression is affected in Gdf11 −/− embryos at the caudal region by whole mount in situ hybridization (WISH) on E9.5 and E10.5 WT and Gdf11 −/− embryos using a Cyp26a1 anti-sense probe. As shown in Fig. 3G , Cyp26a1 transcripts were reduced and detected only at the tail tip region in E9.5 Gdf11 −/− embryos. A similar pattern with a more dramatic difference of expression level was observed in E10.5 Gdf11 −/− embryos in comparison with their WT littermates (Fig. 3B, H Baker et al., 2006; Gregg, 2007; Sakai et al., 2001) . To determine whether the expression levels of these genes were also affected in Gdf11 −/− embryos, we performed WISH using Fgf8 and Wnt3a anti-sense probes. The Wnt3a expression appeared to be slightly reduced in E9.5 and markedly diminished in E10.5 Gdf11 −/− embryos (Fig. 3I,  J) . However, the level of Fgf8 expression did not appear to be significantly affected in E9.5 and E10.5 Gdf11 −/− embryos (Fig. 3K, L) .
In vivo RA activity gradient is altered in Gdf11-null embryos
To investigate whether the reduced and posteriorly-shifted Cyp26a1 expression domain in Gdf11 −/− embryos affects RA activity along the AP axis in Acvr2b and Gdf11 mutants, we examined the in vivo RA activity in Acvr2b −/− , Gdf11 −/− , and control embryos using a RA reporter line (RARE-lacZ-transgenic mice) in which LacZ expression is regulated by retinoic acid response elements (RARE) (Rossant et al., 1991) . E10.5 control and mutant embryos were stained with X-gal followed by WISH with an MesP2 anti-sense probe (Takahashi et al., 2000) to visualize the junction between the PSM and the first mature somite (S0). In WT, Acvr2b +/− , and Gdf11 +/− embryos, the posterior-most X-gal positive somite was found on 9 th , 10 th , or 11 th mature somite (S9-S11) (Fig. 4A) . The RA activity domain in Acvr2b −/− embryos was extended slightly posteriorly compared to that in WT embryos, in which the posterior-most X-gal positive somite was detected on S7-S8 (Fig. 4B) . However, a dramatic posterior shift of the RA activity domain was observed in Gdf11 −/− embryos (Fig. 4C) . In most cases, RA activity was detected on S0 near the rostral end of the PSM.
To investigate the timing of this caudal-shift, we examined the pattern of RA activity in earlier stages of WT and Gdf11 −/− embryos. As shown in Figure 5A and 5B, the posterior-most Xgal positive somite was found at S1 in both control (n=4) and Gdf11 −/− embryos (n=7) at E9.5. At E10.0, RA activity was undetectable in nascent somites of control embryos, as the posteriormost X-gal positive somite was detected in S4 (Fig. 5C, C' ), whereas RA activity was detected in nascent somites of Gdf11 −/− embryos (n = 2) (Fig. 5D, D' ). These results demonstrate that RA activity is progressively shifted in the anterior direction, (i.e., RA activity is inhibited in nascent somites) in the period between E9.5 and E10.5 in WT embryos, whereas this anterior shift of the RA activity domain did not occur in Gdf11 −/− embryos. Taken together, these results suggest that down-regulation of Cyp26a1 expression in the PSM region of Gdf11 −/− embryos impairs inactivation of RA activity in nascent somites at E9.5 -E10.5 stages, resulting in an expansion of the RA activity domain to the caudal region of Gdf11 −/− embryos.
Although the RA activity did not appear to be greatly affected in Acvr2b −/− embryos (Fig. 4B) , we investigated the possibility that the hypersensitivity of Acvr2b −/− and Acvr2a +/− ;Acvr2b −/− embryos to exogenous RA treatment (Fig. 1) (Oh and Li, 1997 ) might reflect differences in levels of Cyp26a1 expression in mutant embryos. To test this, we examined the RA activity in E10.5 Acvr2b +/− and Acvr2b −/− embryos treated with RA at 8.5 dpc. As shown in Fig. 6A , exogenous RA treatment did not alter the RA activity domain in Acvr2b +/− or WT (data not shown) embryos. However, the RA treatment shifted the RA activity domain in the posterior direction in Acvr2b −/− embryos (Fig. 6C) .
Reduced expression or activity of Cyp26a1 affects vertebral patterning
It has been shown that Cyp26a1 −/− mice display severe truncations of tail vertebrae and a mild vertebral patterning defect represented by a C6T14L5 or C6T15L5 pattern that includes a posterior transformation in the cervicothoracic transition and an anterior transformation in the thoracolumbar transition (Abu-Abed et al., 2001; Sakai et al., 2001) . Hence, the vertebral specification defects of Cyp26a1 −/− mice are very different from those of Gdf11 −/− mice. Together with our expression data showing that Cyp26a1 expression is reduced or posteriorly shifted but not absent in Gdf11 −/− embryos (Fig. 3G, H) , these findings suggested that the vertebral phenotype in Gdf11 −/− mice may in part be due to dysregulation rather than complete repression of Cyp26a1. In order to investigate whether a reduction in expression or activity of CYP26A1 can affect vertebral patterning and/or development of tail vertebrae, we employed both genetic and pharmacological approaches.
The vertebral phenotype of Acvr2b −/− mice is sensitive to additional mutation of genes in the same or counteracting signaling pathway and can be either alleviated or intensified depending on further inhibition of BMP or GDF11 signaling, respectively (Andersson et al., 2006; Oh et al., 2002; Park et al., 2004 ). Therefore, we examined possible genetic interactions between Acvr2b and Cyp26a1 by comparing the vertebral patterns of Acvr2b −/− ;Cyp26a1 +/− newborn pups with those of Acvr2b −/− and Acvr2b +/− ;Cyp26a1 +/− littermates (Supplemental Fig. 1) . Out of nine litters, we have obtained eight Acvr2b +/− ;Cyp26a1 +/− , nine Acvr2b −/− , and ten Acvr2b −/− ;Cyp26a1 +/− mice. All eight double heterozygous pups and eight out of nine Acvr2b −/− pups exhibited the normal C7T13L6 pattern and the typical C7T16L6 pattern, respectively. Six out of ten Acvr2b −/− ;Cyp26a1 +/− pups, however, exhibited partial lumbar to thoracic transformation at V24 and therefore exhibited a C7T17(s)L5 pattern.
As an alternative approach, we attempted to reduce the CYP26A1 activity by administering a pharmacological inhibitor of CYP26 enzymes, R115866 (Johnson & Johnson Co) . It has been shown that oral administration of this compound into rats can alter levels of RA signaling in vivo (Stoppie et al., 2000) . It has never been tested, however, whether this compound can efficiently inhibit Cyp26 enzymes in embryos and whether such inhibition would affect vertebral patterning. We first examined the effect of administering the drug to WT pregnant dams at 8.5 dpc via oral gavage in various concentrations ranging from 2.5-20 mg/kg of bw. At 20 mg/kg bw, all nine fetuses exhibited cleft palate and small mandible, and some also exhibited an opened-eye phenotype (data not shown). Interestingly, seven out of nine exhibited mild anterior transformation of vertebrae, such as C7T14L6 (n=3), C7T14L5 (n=3), or C7T14 (s)L5 (n=1) (Supplemental Fig. 2A,B) .
In order to test the impact of this CYP26 inhibitor on Acvr2b −/− background, we analyzed the vertebral patterns of E18.5 fetuses treated with the drug (10 mg/kg bw) at 8.5 dpc. At this dosage, none of the WT and Acvr2b +/− fetuses (n=7) exhibited vertebral defects (Supplemental Fig. 2C ), whereas Acvr2b −/− fetuses displayed more exaggerated vertebral transformation defects in comparison with the unexposed Acvr2b −/− mice (Supplemental Fig. 2D, E) . One of treated mice was found dead and exhibited the C7T18L4 pattern with a severe truncation of tail vertebrae (Supplemental Fig. 2E ). These genetic and pharmacological data provide further support for our model that dysregulation of RA homeostasis mediated by CYP26A1 is an important contributing factor for the axial vertebral defects observed in Acvr2b −/− and Gdf11 −/− mice. Elevated RA activity is partially responsible for axial vertebral defects in Gdf11-null mice RA signaling is mediated by retinoic acid receptors (RARA, RARB, and RARG) and retinoid X receptors (RXRA, RXRB, and RXRG) (Mark et al., 2009) . It has been shown that RARG is the crucial gene for axial vertebral development. Rarg is expressed in the tail bud and the PSM, and Rarg-deletion has been shown to rescue the vertebral defects of Cyp26a1 −/− mutants (Abu-Abed et al., 2003) . In order to evaluate the extent to which impaired RA homeostasis affects the vertebral defects in Gdf11 −/− mice, we attempted to block the RA signaling using a pan retinoic acid receptor antagonist, AGN193109 (Johnson et al., 1995; Agarwal et al., 1996) . We analyzed axial skeletons of E18.5 WT and Gdf11 −/− fetuses treated with AGN193109 at 8.5 and/or 9.5 dpc, a crucial developmental period for vertebral specification and tail development. Most WT embryos treated with vehicle or AGN193109 (oral administration, 2 mg/kg of bw) at 8.5 dpc exhibited the normal vertebral pattern (C7T13L6) and had 24-29 caudal vertebrae (average: 27 caudal vertebrae; Fig. 7A ; Supplemental Fig. 3A,  B) . Alough the posterior transformation phenotype at the cervicothoracic junction was unaffected, treatment with the drug could almost completely rescue the caudal defects of Cyp26a1 −/− mutants ( Fig. 7B; Supplemental Fig. 3C, D) , demonstrating the effectiveness of this regimen. Vehicle-treated Gdf11 −/− embryos showed typical C7T18L8 or C7T18L7 patterns with truncation of tails (average: 2.5 caudal vertebrae; Fig. 7C; Supplemental Fig. 3E,  F) . The treatment of AGN193109 for two consecutive days at 8.5 and 9.5 dpc markedly rescued the tail truncation defect of Gdf11 −/− fetuses (average: 16.6 caudal vertebrae; Fig. 7D ; Supplemental Fig. 3G-I) . Drug treatment at either 8.5 or 9.5 dpc could also rescue the tail truncation defect of Gdf11 −/− but to a less extent than that seen with the two day treatment (average: 11 caudal vertebrae; Fig. 7E, F) . The effect by the RA signaling inhibitor in terms of rescuing the anterior transformation phenotype of Gdf11 −/− mice was not as dramatic as that seen in terms of rescuing the tail defect, with the number of thoracic vertebrae being reduced to 17 with two days of drug treatment (Supplemental Fig. 3G-I ). We did not include the number of lumbar vertebrae for comparison because it was difficult to identify the first sacral vertebra to accurately count the number of lumbar vertebrae.
Gdf11 −/− mice display defects in development of axial vertebrae, characterized by severe anterior vertebral transformation and agenesis of caudal vertebrae. Here we have demonstrated that regulation of RA metabolism by CYP26A1 in the PSM/tailbud region is a key downstream mechanism by which GDF11 signaling controls the development of caudal vertebrae. Specifically, we showed that Gdf11 −/− embryos have diminished expression of Cyp26a1 in the tail bud region and impaired inactivation of RA in nascent somites at E9.5 and E10.5 and that diminished levels of CYP26A1 also correlates with hyper-sensitivity of Acvr2a/b and Gdf11 mutant mice to exogenous RA exposure. Furthermore, we showed that treatment of embryos with a RARG antagonist could rescue the caudal agenesis phenotype of Gdf11 −/− mice. Interestingly, the RARG antagonist rescued truncation of caudal vertebrae of Gdf11 −/− mice, but the morphology of the rescued caudal vertebrae was abnormal. In WT mice, a morphological transition (i.e., absence of transverse and spinous processes) occurs at the 5 th or 6 th caudal vertebra (Fig, 7A inset) . Such a transition was present in the rescued caudal vertebrae of Cyp26a1 −/− mice (Fig, 7B inset) but not in those of Gdf11 −/− mice (Fig. 7D-F) . Although additional studies will be required to determine the extent to which other downstream mediators are required for correct specification of caudal vertebrae, the data presented here strongly suggest that Cyp26a1 is an essential downstream target of GDF11-ACVR2 signaling and that dysregulation of RA metabolism is at least partially responsible for the patterning defects seen in Gdf11 mutant mice. Hence, our studies are consistent with a direct relationship between the pathways regulated by GDF11 and by retinoic acid in establishing positional identity along the anterior-posterior axis and raise the possibility that these signaling pathways may also interact in regulating other developmental processes.
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FIG. 1.
Acvr2a/b and Gdf11 mutants are sensitive to exogenous RA exposure. Representative ventral view of axial skeletons of wild-type (A, B), Acvr2a +/− ;Acvr2b −/− (C-E), and Gdf11 −/− (F-H) fetuses exposed to either sesame oil (A, C, F) or RA (B, D, E, G, H) in utero at 8.5 dpc (10 mg/kg of body weight). Limbs were removed during skeleton preparation. Diagram with colored boxes in each panel indicate a represented number of cervical (C; red), thoracic (T; blue), lumbar (L; orange), sacral (S; green), and caudal (Cd; dark blue) vertebrae. Severe truncations of the axial skeletons occurred posterior to mid-lumbar region in RA exposed Acvr2 mutants and Gdf11 −/− fetuses.
FIG. 2.
Gdf11 expression domain overlaps with Cyp26a1 expression in the PSM region. Whole mount in situ hybridization of Aldh1a2 (A), Cyp26a1 (B), and Gdf11 (C) in wild-type embryos at E9.0-E9.5 revealed that Gdf11 expression in the PSM region (indicated by orange lines) overlaps with Cyp26a1 but mutually exclusive with Aldh1a2 expression. MesP2 expression is indicated by an arrow head (C).
FIG. 4.
Posteriorized RA activities in the caudal region of the Gdf11 −/− embryos. RA activities were visualized by X-gal staining in RARE-LacZ(+);Gdf11 +/− (A), RARE-LacZ(+);Acvr2b −/− (B), and RARE-LacZ(+);Gdf11 −/− (C) E10.5 embryos. Lower panels are magnified views of posterior regions of the corresponding embryo. Asterisks and arrows indicate the posteriormost X-gal positive somite and MesP2 expression, respectively. MesP2 marks for the junction between the posterior-most somite and the PSM region.
